These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10648077)
1. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Yano M; Doki Y; Inoue M; Tsujinaka T; Shiozaki H; Monden M Surg Today; 2000; 30(1):16-21. PubMed ID: 10648077 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Suzuki Y; Kamigaki T; Fujino Y; Tominaga M; Ku Y; Kuroda Y Br J Surg; 2003 Sep; 90(9):1072-5. PubMed ID: 12945073 [TBL] [Abstract][Full Text] [Related]
3. [The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit]. Hiramatsu N; Hashimoto S; Fujita N; Kageyama K; Ashida H; Kimura A; Kobayashi A; Tanaka Y Masui; 2000 Aug; 49(8):867-71. PubMed ID: 10998878 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients. Miyake M; Ohbayashi Y; Iwasaki A; Ogawa T; Nagahata S J Oral Maxillofac Surg; 2007 Nov; 65(11):2159-63. PubMed ID: 17954308 [TBL] [Abstract][Full Text] [Related]
6. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. Kim DH; Spencer M; Davidson SM; Li L; Shaw JD; Gulczynski D; Hunter DJ; Martha JF; Miley GB; Parazin SJ; Dejoie P; Richmond JC J Bone Joint Surg Am; 2010 Aug; 92(9):1820-6. PubMed ID: 20610773 [TBL] [Abstract][Full Text] [Related]
7. Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment. Coskun D; Aytac J J Hosp Infect; 2004 Sep; 58(1):90-1. PubMed ID: 15350723 [No Abstract] [Full Text] [Related]
9. Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus aureus surgical site infection. Pofahl WE; Ramsey KM; Nobles DL; Cochran MK; Goettler C Am Surg; 2011 Jan; 77(1):27-31. PubMed ID: 21396301 [TBL] [Abstract][Full Text] [Related]
10. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit. Dupeyron C; Campillo B; Richardet JP; Soussy CJ J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100 [TBL] [Abstract][Full Text] [Related]
12. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Ridenour G; Lampen R; Federspiel J; Kritchevsky S; Wong E; Climo M Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1155-61. PubMed ID: 17828692 [TBL] [Abstract][Full Text] [Related]
13. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol; 1996 Nov; 7(11):2403-8. PubMed ID: 8959632 [TBL] [Abstract][Full Text] [Related]
14. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. van Rijen MM; Bonten M; Wenzel RP; Kluytmans JA J Antimicrob Chemother; 2008 Feb; 61(2):254-61. PubMed ID: 18174201 [TBL] [Abstract][Full Text] [Related]
15. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. Fawley WN; Parnell P; Hall J; Wilcox MH J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029 [TBL] [Abstract][Full Text] [Related]
16. Impact of prophylactic mupirocin for radical esophagectomy. Unemura Y; Ishida Y; Suzuki Y; Yanaga K J Infect Chemother; 2006 Oct; 12(5):257-63. PubMed ID: 17109088 [TBL] [Abstract][Full Text] [Related]
17. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707 [TBL] [Abstract][Full Text] [Related]
18. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Nicholson MR; Huesman LA Am J Infect Control; 2006 Feb; 34(1):44-8. PubMed ID: 16443093 [TBL] [Abstract][Full Text] [Related]
19. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636 [TBL] [Abstract][Full Text] [Related]
20. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward. Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]